Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Atrial Fibrillation Market is Expected to Reach $8,319 Million by 2022, Globally - Allied Market Research

Allied Market Research
Posted on: 24 Nov 16

PORTLAND, Oregon and PUNE, India, November 23, 2016 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, Atrial Fibrillation Market by Device Type, By Geography - Global Opportunity Analysis and Industry Forecast, 2014 - 2022 is poised to reach $8,319 million by 2022, registering a CAGR of 13.0% from 2016 to 2022. Non-surgical devices segment dominated the overall market in 2015. North America was the leading geographic segment in global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period.

Rise in prevalence rate of atrial fibrillation in geriatric population, technological advancements in devices, improvement of healthcare infrastructure in developing countries, development of minimally invasive procedures, and increase in patient awareness propel the market growth. However, dearth of skilled professionals and unfavorable preference to pharmaceutical drugs hamper the growth of the market.

Summary of the Atrial Fibrillation Market Report can be accessed on the website at: https://www.alliedmarketresearch.com/atrial-fibrillation-market

Catheter ablation is the highest revenue contributor and is expected to grow at the highest CAGR of 13.8% in the analysis period. This growth is owing to the technological advancements such as cryoFORM, which offers increased flexibility that allows easy manipulation and treatment during surgical process. In addition, increase in preference of catheter ablation for cardiac arrhythmia treatment over other devices as this is the safer and minimally invasive surgical procedures used for the treatment of atrial fibrillation.

Asia-Pacific is expected to be the fastest growing region with a CAGR of 14.7% during the forecast period. Japan accounted for the highest share of the total Asia-Pacific market in 2015; while China is poised to grow at highest CAGR during the analysis period (20162022). This growth in this region is attributed to the rise in the prevalence of cardiac arrhythmia in developing countries (such as India and China) owing to the large geriatric population.

Key findings of the Atrial Fibrillation Market 

North America dominated the market of atrial fibrillation and is expected to maintain its lead throughout the forecast period, with a CAGR of 12.1%

By country, U.S. generates the highest revenue in 2015

Asia-Pacific is the fastest growing market and is estimated to grow at a CAGR of 14.7%

Japan accounted for more than one-third share of the Asia-Pacific atrial fibrillation devices market in 2015

The non-surgical equipment segment dominated in 2015, occupying largest revenue share and is anticipated to grow at a CAGR of 12.5%

Catheter ablation (sub segment for surgical equipment) accounted for largest market share in 2015 and is anticipated to grow at a CAGR of 13.8%

Cryoablation, a sub type of catheter ablation, is projecting the highest CAGR of 14.6% during the study period

North America accounted for the major share in the global atrial fibrillation devices market in 2015, and is expected to maintain its leading position throughout forecast period. This is attributable to the increase in prevalence of atrial fibrillation in geriatric population and high adoption of advanced technologies for the treatment of AF.

Key players have adopted product development as their key strategy to cater to the changing needs of the industry. Major players that operate in this market include Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., Medtronic plc, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc.

Read similar market research reports on Medical Devices at: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Rahul Thakur
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com

Website: https://www.alliedmarketresearch.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 24/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.